Revenue
2022
2023
2024
2025
FibroBiologics, Inc. (FBLG)
Price$1.81Cached quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & development | $7.4M | $4.5M | $2.4M | $1.1M |
| Operating expenses | $16.6M | $13.7M | $8.9M | $4.5M |
| Operating income | −$16.6M | −$13.7M | −$8.9M | −$4.5M |
| EBITDA | −$16.4M | −$13.6M | −$8.8M | −$4.4M |
| Net income | −$18.6M | −$11.2M | −$16.5M | −$5.1M |
| Basic EPSper basic share | -$8.40 | -$6.80 | -$13.60 | -$3.60 |
| Diluted EPSper diluted share | -$8.40 | -$6.80 | -$13.60 | -$3.60 |
Owners
Reported shareholders
≈97.99%of listed shares
O'HEERON PETE5.96M shares · Mar 4, 2026
View holders
| Holder | % owned |
|---|---|
O'HEERON PETE | ≈97.99%5.96M shares |
GARCIA RUBEN A | ≈2.96%180K shares |
Cascade Financial Partners, LLC | 1.79%108.83K shares |
Davis Jason | ≈1.15%70K shares |
Khoja Hamid | ≈1.01%61.25K shares |
Fund Evaluation Group, LLC | 0.85%51.79K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.50%30.3K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.46%27.77K shares |
Qube Research & Technologies Ltd | 0.40%24.31K shares |
BlackRock, Inc. | 0.30%18.24K shares |
BARCLAYS PLC | 0.12%7.24K shares |
VANGUARD FIDUCIARY TRUST CO | 0.10%6.38K shares |
Tower Research Capital LLC (TRC) | 0.08%4.73K shares |
OSAIC HOLDINGS, INC. | 0.04%2.4K shares |
ROYAL BANK OF CANADA | 0.03%1.52K shares |
UBS Group AG | 0.02%1.07K shares |
ISLAY CAPITAL MANAGEMENT, LLC | <0.01%169 shares |
Grove Bank & Trust | <0.01%100 shares |
BNP PARIBAS FINANCIAL MARKETS | <0.01%64 shares |
Allworth Financial LP | <0.01%13 shares |
Percentages use 6.08M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Reported positions exceed 100% in total, so the circle shows the selected holder only.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 4, 2026Form 4 | Khoja HamidChief Scientific Officer | BuyCommon Stock | 30.0K | $0.38 | $11.4K | 61.3K |
| Mar 4, 2026Form 4 | O'HEERON PETECHIEF EXECUTIVE OFFICER | BuyCommon Stock | 15.9K | $0.38 | $6.0K | 5.96M |
| Mar 3, 2026Form 4 | O'HEERON PETECHIEF EXECUTIVE OFFICER | BuyCommon Stock | 18.2K | $0.41 | $7.5K | 5.94M |
| Mar 2, 2026Form 4 | O'HEERON PETECHIEF EXECUTIVE OFFICER | BuyCommon Stock | 17.4K | $0.35 | $6.1K | 5.92M |
| Mar 2, 2026Form 4 | Davis JasonChief Financial Officer | BuyCommon Stock | 70.0K | $0.41 | $28.7K | 70.0K |